0001209191-18-039730.txt : 20180627 0001209191-18-039730.hdr.sgml : 20180627 20180627200037 ACCESSION NUMBER: 0001209191-18-039730 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180625 FILED AS OF DATE: 20180627 DATE AS OF CHANGE: 20180627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pope Todd CENTRAL INDEX KEY: 0001584367 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 18922937 MAIL ADDRESS: STREET 1: C/O TRANSENTERIX STREET 2: 635 DAVIS DRIVE, SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27713 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-25 0 0000876378 TRANSENTERIX INC. TRXC 0001584367 Pope Todd C/O TRANSENTERIX, INC. 635 DAVIS DRIVE, SUITE 300 MORRISVILLE NC 27560 1 1 0 0 President and CEO Common Stock 2018-06-25 4 M 0 138555 0.35 A 454627 D Common Stock 2018-06-25 4 S 0 100000 4.35 D 354627 D Common Stock 2018-06-25 4 M 0 61445 0.35 A 416072 D Common Stock 2018-06-25 4 S 0 100000 4.85 D 316072 D Common Stock 2018-06-26 4 M 0 160086 0.35 A 476158 D Common Stock 2018-06-26 4 S 0 160086 5.35 D 316072 D Stock Option 0.35 2018-06-25 4 M 0 138555 0.00 D 2015-03-02 2022-04-12 Common Stock 138555 0 D Stock Option 0.35 2018-06-25 4 M 0 61445 0.00 D 2013-06-02 2022-04-12 Common Stock 61445 221258 D Stock Option 0.35 2018-06-26 4 M 0 160086 0.00 D 2014-10-02 2022-04-12 Common Stock 160086 61172 D The identified transactions set forth on this Form 4 were made pursuant to a Rule 10b5-1(c) sales plan executed by the reporting person on August 9, 2017, as amended on September 20, 2017. Following the sales on June 25, 2018 and June 26, 2018, the reporting person continues to beneficially own 316,072 shares of the company's common stock. The reporting person also holds stock options to acquire 4,035,262 shares of common stock, of which approximately 47% are vested, and restricted stock units representing an additional 2,226,555 shares of common stock subject to forfeiture restrictions. /s/ Joshua Weingard, as Attorney-in-Fact for Todd Pope 2018-06-27